Dissolved and financials
CVR: 42378666
DKK 108,945
Gross profit
Net result: DKK 84,991
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 12 December 2024
CVR · view overview
0 employees
Annual report 2023 · average
Director role ended: Svend Kaj Petersen
CVR · 12/12/2024
View the full event history
neu biologica ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2021. The company has been dissolved on 12 December 2024. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK 108,945 and a net result of DKK 84,991. Equity in the 2023 report amounted to DKK 98,173.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/07/2022 – 30/06/2023 | 109 t. | 85 t. | 162 t. | 98 t. | 0 |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. neu biologica ApS is registered in the Danish CVR register with the status Dissolved and ceased on 12 December 2024.
The CVR number of neu biologica ApS is 42378666.
In 2023, neu biologica ApS reported a gross profit of DKK 108,945.
neu biologica ApS had an average of 0 employees in the 2023 financial year according to the annual report.
neu biologica ApS was founded on 8 May 2021.
neu biologica ApS was registered under the industry Konsulentbistand vedrørende informationsteknologi (industry code 620200).
As of December 12, 2024, Svend Kaj Petersen has stepped down as director of neu biologica ApS.
Neu biologica ApS was dissolved on December 12, 2024.
Neu biologica ApS has published its annual report for 2023. Gross profit came to DKK 108,945, and the net result was DKK 84,991.
Neu biologica ApS has published its interim report for the period May 8, 2021 – June 30, 2022.
As of May 8, 2021, Svend Kaj Petersen is registered as director of neu biologica ApS.
Neu biologica ApS was founded on May 8, 2021.
